Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation

Xiaoxi Yao, Neena S. Abraham, Lindsey R. Sangaralingham, M. Fernanda Bellolio, Robert D. McBane, Nilay D. Shah, Peter A. Noseworthy

Research output: Contribution to journalArticlepeer-review

257 Scopus citations

Fingerprint

Dive into the research topics of 'Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation'. Together they form a unique fingerprint.

Medicine & Life Sciences